{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:35:49Z","timestamp":1786527349982,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xphs.2025.104109","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:39:08Z","timestamp":1764175148000},"page":"104109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Crux of vehicle designations: The essence of topical dermatologic vehicles and their use"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5027-4112","authenticated-orcid":false,"given":"Christian","family":"Surber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Herbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Reinau-H\u00e4berlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.104109_bib0001","series-title":"StatPearls [Internet]","article-title":"Cosmeceuticals","author":"Pandey","year":"2023"},{"issue":"3","key":"10.1016\/j.xphs.2025.104109_bib0002","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/120347540100500304","article-title":"Dermatologists and allergists have far more experience and use more complex treatment regimens in the treatment of atopic dermatitis than other physicians","volume":"5","author":"Henderson","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.xphs.2025.104109_bib0003","unstructured":"Topical drugs Market size, share & trends analysis report by type (Semi-solid, Liquid), by route of administration (Dermal, Ophthalmic), by end-use (Burn Centers, Hospitals & Clinics), by region, and segment forecasts, 2022 - 2030. https:\/\/www.grandviewresearch.com\/industry-analysis\/topical-drugs-market-report, Assessed 24 June 2025."},{"key":"10.1016\/j.xphs.2025.104109_bib0004","unstructured":"European Medicines Agency. Medicinal product: https:\/\/www.ema.europa.eu\/en\/glossary\/medicinal-product, Assessed 24 June 2025."},{"key":"10.1016\/j.xphs.2025.104109_bib0005","unstructured":"European Medicines Agency. Medical device: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/medical-devices, Assessed 24 June 2025."},{"key":"10.1016\/j.xphs.2025.104109_bib0006","unstructured":"Consolidated text: regulation (EC) No 1223\/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (version 24.04.24). https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:02009R1223-20190813, Assessed 24 June 2025."},{"key":"10.1016\/j.xphs.2025.104109_bib0007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000489532","article-title":"Skin care products for healthy and diseased Skin","volume":"54","author":"Surber","year":"2018","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.xphs.2025.104109_bib0008","first-page":"1","article-title":"Liposomes in the cosmetics: present and outlook","volume":"7","author":"Huang","year":"2024","journal-title":"J Liposome Res"},{"issue":"3","key":"10.1016\/j.xphs.2025.104109_bib0009","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/pharmaceutics16030309","article-title":"Liposomes and other nanocarriers for the treatment of acne Vulgaris: improved therapeutic efficacy and skin tolerability","volume":"16","author":"Dragicevic","year":"2024","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.xphs.2025.104109_bib0010","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/pharmaceutics16050661","article-title":"Beyond traditional sunscreens: a review of liposomal-based systems for photoprotection","volume":"16","author":"Miranda","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.104109_bib0011","doi-asserted-by":"crossref","DOI":"10.1021\/acsabm.4c00395","article-title":"Understanding mucosal physiology and rationale of formulation design for improved mucosal immunity","author":"Biswas","year":"2024","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"10.1016\/j.xphs.2025.104109_bib0012","doi-asserted-by":"crossref","first-page":"e1918","DOI":"10.1002\/wnan.1918","article-title":"Transferosomes as a transdermal drug delivery system: dermal kinetics and recent developments","volume":"16","author":"Matharoo","year":"2024","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"13","key":"10.1016\/j.xphs.2025.104109_bib0013","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.3390\/polym14132633","article-title":"A poly (Caprolactone)-cellulose nanocomposite hydrogel for transdermal delivery of hydrocortisone in treating psoriasis Vulgaris","volume":"14","author":"Kondiah","year":"2022","journal-title":"Polymers"},{"issue":"8","key":"10.1016\/j.xphs.2025.104109_bib0014","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1007\/s13346-024-01614-w","article-title":"Drug delivery to and through the skin","volume":"14","author":"Guy","year":"2024","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.xphs.2025.104109_bib0015","unstructured":"European Pharmacopoeia, 11.0, praeparationes semi solidae ad usum dermicum. 1001-1003. online viewed 2.9.25."},{"key":"10.1016\/j.xphs.2025.104109_bib0016","unstructured":"USP-NF, (1151) Pharmaceutical dosage Forms, online viewed 2.9.25."},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.104109_bib0017","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2005.01.032","article-title":"Topical drug classification","volume":"295","author":"Buhse","year":"2005","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.104109_bib0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijpharm.2015.06.011","article-title":"A science-based approach to topical drug classification system (TCS)","volume":"491","author":"Shah","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.104109_bib0019","unstructured":"European Medicines Agency. European Medicines Agency. Draft guideline on quality and equivalence of topical products. EMA\/CHMP\/QWP\/708282\/2018 corr.1, April 2025."},{"key":"10.1016\/j.xphs.2025.104109_bib0020","article-title":"Physicochemical and structural (Q3) characterization of topical drug products submitted in ANDAs guidance for industry","year":"2022","journal-title":"DRAFT GUIDANCE"},{"key":"10.1016\/j.xphs.2025.104109_bib0021","series-title":"Voigt\u2019s Pharmaceutical Technology","author":"Fahr","year":"2018"},{"key":"10.1016\/j.xphs.2025.104109_bib0022","series-title":"Aulton's Pharmaceutics","author":"Aulton","year":"2018"},{"issue":"7","key":"10.1016\/j.xphs.2025.104109_bib0023","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3390\/pharmaceutics15071822","article-title":"Rational design of topical semi-solid dosage forms-how far are we?","volume":"15","author":"Herbig","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.xphs.2025.104109_bib0024","first-page":"374","article-title":"Geschichte der dermatologie 100 jahre \u00e4usserliche behandlung von hautkrankheiten: von der empirie zur pharmakologisch begr\u00fcndeten dermatotherapie [100 years of external treatment of skin diseases: from empirism to pharmacologically-based dermatotherapy]","volume":"26","author":"Braun-Falco","year":"1975","journal-title":"Hautarzt"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.104109_bib0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2013.02.040","article-title":"Skin penetration enhancers","volume":"447","author":"Lane","year":"2013","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2025.104109_bib0026","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000346273","article-title":"Occlusion effect on in vivo percutaneous penetration of chemicals in man and monkey: partition coefficient effects","volume":"26","author":"Hafeez","year":"2013","journal-title":"Skin Pharmacol Physiol"},{"issue":"1","key":"10.1016\/j.xphs.2025.104109_bib0027","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12895-016-0051-4","article-title":"Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a phase 2b randomized clinical trial","volume":"16","author":"Papp","year":"2016","journal-title":"BMC Dermatol"},{"issue":"1","key":"10.1016\/j.xphs.2025.104109_bib0028","first-page":"5","article-title":"Steroid-sparing properties of emollients in dermatology","volume":"19","author":"Harcharik","year":"2014","journal-title":"Skin Therapy Lett"},{"issue":"6","key":"10.1016\/j.xphs.2025.104109_bib0029","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/ced.15141","article-title":"Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis","volume":"47","author":"Danby","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.xphs.2025.104109_bib0030","article-title":"Skin care interventions in infants for preventing eczema and food allergy","volume":"2","author":"Kelleher","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.xphs.2025.104109_bib0031","article-title":"Emollients and moisturisers for eczema","volume":"2","author":"van Zuuren","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 7","key":"10.1016\/j.xphs.2025.104109_bib0032","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jdv.15960","article-title":"Often misrepresented yet fundamental: the importance of understanding ingredients in cosmetics","volume":"33","author":"Ring","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.104109_bib0033","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2014.01.017","article-title":"Development and evaluation of a tacrolimus cream formulation using a binary solvent system","volume":"464","author":"Yamanaka","year":"2014","journal-title":"Int J Pharm"},{"issue":"2 Suppl 2","key":"10.1016\/j.xphs.2025.104109_bib0034","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.12788\/j.sder.0023","article-title":"The chemistry of skin cleansers: an overview for clinicians","volume":"32","author":"Fowler","year":"2013","journal-title":"Semin Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.xphs.2025.104109_bib0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2340\/0001555572327330","article-title":"The increase in skin hydration after application of emollients with different amounts of lipids","volume":"72","author":"Lod\u00e9n","year":"1992","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"10.1016\/j.xphs.2025.104109_bib0036","first-page":"470","article-title":"Grundprinzipien der dermatologischen Lokaltherapie [Basic principles in local dermatologic therapy]","volume":"55","author":"Pflugshaupt","year":"1998","journal-title":"Ther Umsch"},{"issue":"5","key":"10.1016\/j.xphs.2025.104109_bib0037","first-page":"582","article-title":"A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay","volume":"13","author":"Kircik","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.xphs.2025.104109_bib0038","first-page":"345","article-title":"Study on the occlusivity of oil films","volume":"30","author":"Tsutsumi","year":"1979","journal-title":"J Soc Cosmet Chem"},{"key":"10.1016\/j.xphs.2025.104109_bib0039","first-page":"157","article-title":"Factors in the occlusivity of aqueous emulsions","volume":"33","author":"Wepierre","year":"1982","journal-title":"J Soc Cosmet Chem"},{"issue":"4","key":"10.1016\/j.xphs.2025.104109_bib0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2133.1976.tb00844.x","article-title":"Proprietary hydrocortisone creams. Vasoconstrictor activities and bio-availabilities of six preparations","volume":"95","author":"Barry","year":"1976","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.xphs.2025.104109_bib0041","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/A:1012089803281","article-title":"Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing","volume":"14","author":"Demana","year":"1997","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2025.104109_bib0042","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0939-6411(98)00094-0","article-title":"Analysis of chromameter results obtained from corticosteroid-induced skin blanching assay: comparison of visual and chromameter data","volume":"47","author":"Schwarb","year":"1999","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.104109_bib0043","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archderm.1985.01660010067020","article-title":"Correlation of the vasoconstriction assay and clinical activity in psoriasis","volume":"121","author":"Cornell","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xphs.2025.104109_sbref0044","series-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Goldsmith","year":"2012"},{"issue":"4","key":"10.1016\/j.xphs.2025.104109_bib0045","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000447672","article-title":"Topical treatment of infantile haemangiomas: a comparative study on the selection of a semi-solid vehicle","volume":"29","author":"Casiraghi","year":"2016","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.xphs.2025.104109_bib0046","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejpb.2016.08.011","article-title":"Quercetin topical application, from conventional dosage forms to nanodosage forms","volume":"108","author":"Hatahet","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.104109_bib0047","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2014.01.017","article-title":"Development and evaluation of a tacrolimus cream formulation using a binary solvent system","volume":"464","author":"Yamanaka","year":"2014","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2025.104109_bib0048","first-page":"34","article-title":"Topical drug delivery and the role of excipients","volume":"40","author":"Herbig","year":"2022","journal-title":"Chem Today"},{"issue":"3","key":"10.1016\/j.xphs.2025.104109_bib0049","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s13555-016-0125-6","article-title":"Supersaturation of calcipotriene and betamethasone dipropionate in a novel aerosol foam formulation for topical treatment of psoriasis provides enhanced bioavailability of the active ingredients","volume":"6","author":"Lind","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.xphs.2025.104109_bib0050","first-page":"23","article-title":"Evaporation from complex emulsion system","volume":"44","author":"Langlois","year":"1993","journal-title":"J Soc Cosmet Chem"},{"key":"10.1016\/j.xphs.2025.104109_bib0051","series-title":"Dermatological and Transdermal Formulations","first-page":"401","article-title":"Bioavailability and bioequivalence of dermatological and transdermal formulations","author":"Surber","year":"2002"},{"issue":"2","key":"10.1016\/j.xphs.2025.104109_bib0052","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000082572","article-title":"The mystical effects of dermatological vehicles","volume":"210","author":"Surber","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.xphs.2025.104109_bib0053","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000489529","article-title":"Metamorphosis of vehicles: mechanisms and opportunities","volume":"54","author":"Surber","year":"2018","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.xphs.2025.104109_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124595","article-title":"Physicochemical characterization of the metamorphosis of film-forming formulations of betamethasone-17-valerate","volume":"664","author":"Zarmpi","year":"2024","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2025.104109_bib0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1208\/s12248-025-01113-x","article-title":"The impact of using measured In vitro data to develop physiologically based pharmacokinetic models of dermal absorption: an IVIVE case study","volume":"27","author":"Patel","year":"2025","journal-title":"AAPS J"},{"issue":"6","key":"10.1016\/j.xphs.2025.104109_bib0056","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/pharmaceutics17060764","article-title":"Solute-vehicle-skin interactions and their contribution to pharmacokinetics of skin delivery","volume":"17","author":"Tapfumaneyi","year":"2025","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.xphs.2025.104109_bib0057","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1517\/17425247.2016.1140146","article-title":"Drug crystallization - implications for topical and transdermal delivery","volume":"13","author":"Hadgraft","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.104109_bib0058","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijpharm.2011.01.025","article-title":"Enhanced permeation of fentanyl from supersaturated solutions in a model membrane","volume":"407","author":"Santos","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.104109_bib0059","series-title":"US patent: US 12,447,161 B2, 21.10","year":"2025"},{"key":"10.1016\/j.xphs.2025.104109_bib0060","series-title":"EU patent: EP 4 108 235 B1, 08.11","year":"2023"},{"issue":"5","key":"10.1016\/j.xphs.2025.104109_bib0061","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1111\/jdv.18797","article-title":"Topical corticosteroid or emollient product: which to apply first?","volume":"37","author":"Surber","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.xphs.2025.104109_bib0062","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1002\/ski2.215","article-title":"Skin permeation and penetration of mometasone furoate in the presence of emollients: an ex vivo evaluation of clinical application protocols","volume":"3","author":"Beebeejaun","year":"2023","journal-title":"Skin Health Dis"},{"key":"10.1016\/j.xphs.2025.104109_bib0063","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000543653","article-title":"How to choose an emollient? Pharmaceutical and sensory attributes for product selection","author":"Huber","year":"2025","journal-title":"Skin Pharmacol Physiol"},{"issue":"3","key":"10.1016\/j.xphs.2025.104109_bib0064","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jamadermatol.2020.5362","article-title":"Shared decision-making in dermatology: a scoping review","volume":"157","author":"Morrison","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.xphs.2025.104109_bib0065","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/bjd.14803","article-title":"Shared decision making and patient decision aids in dermatology","volume":"175","author":"Tan","year":"2016","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.xphs.2025.104109_bib0066","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S2352-4642(22)00146-8","article-title":"Effectiveness and safety of lotion, cream, gel, and ointment emollients for childhood eczema: a pragmatic, randomised, phase 4, superiority trial","volume":"6","author":"Ridd","year":"2022","journal-title":"Lancet Child Adolesc Health"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:59:29Z","timestamp":1786525169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925005635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0022354925005635"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104109","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Crux of vehicle designations: The essence of topical dermatologic vehicles and their use","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104109"}}